| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 30, 2008
Accepted on July 15, 2008
Department of Pharmacology, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242
* To whom correspondence should be addressed. E-mail: mario-ascoli{at}uiowa.edu.
We examine the pathways involved in the lutropin receptor (LHR)-dependent activation of the EGF network using co-cultures of LHR positive granulosa cells and LHR negative test cells expressing an EGF receptor-green fluorescent protein (EGFR-GFP) fusion protein. Activation of the LHR in granulosa cells results in the release of EGF-like growth factors that are detected by measuring the phosphorylation of the EGFR-GFP expressed only in the LHR-negative test cells. Using neutralizing antibodies and real time PCR we identified epiregulin as the main EGF-like growth factor produced upon activation of the LHR expressed in immature rat granulosa cells and we show that exclusive inhibition or activation of the ERK1/2 cascade in granulosa cells prevents or enhances epiregulin release, respectively, with little or no effect on epiregulin expression. These results show that the LHR-stimulated ERK1/2 pathway stimulates epiregulin release.
This article has been cited by other articles:
![]() |
P. Tai, K. Shiraishi, and M. Ascoli Activation of the Lutropin/Choriogonadotropin Receptor Inhibits Apoptosis of Immature Leydig Cells in Primary Culture Endocrinology, August 1, 2009; 150(8): 3766 - 3773. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |